Treatment should not be initiated too soon in Parkinson's disease

被引：19

作者：

Aminoff, MJ ^{[1
]}

机构：

[1] Univ Calif San Francisco, Dept Neurol, Sch Med, San Francisco, CA 94143 USA

来源：

ANNALS OF NEUROLOGY | 2006年 / 59卷 / 03期

关键词：

D O I：

10.1002/ana.20814

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：562 / 564

页数：3

共 22 条

[1] Parkinson's disease: Is the initial treatment established? [J].

J. Eric Ahlskog .

Current Neurology and Neuroscience Reports, 2003, 3 (4) :289-295

[2] Slowing Parkinson's disease progression - Recent dopamine agonist trials [J].

Ahlskog, JE .

NEUROLOGY, 2003, 60 (03) :381-389

[3] Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature [J].

Ahlskog, JE ;

Muenter, MD .

MOVEMENT DISORDERS, 2001, 16 (03) :448-458

[4]

BASMA AN, 1995, J NEUROCHEM, V64, P825

[5] L-DOPA-induced neurotoxic and apoptotic changes on cultured chromaffin cells [J].

Corona-Morales, AA ;

Castell, A ;

Zhang, LM .

NEUROREPORT, 2000, 11 (03) :503-506

[6]

DIAMOND SG, 1990, ADV NEUROL, V53, P399

[7] SELEGILINE AS AN ADJUNCT TO CONVENTIONAL LEVODOPA THERAPY IN PARKINSONS-DISEASE - EXPERIENCE WITH THIS TYPE-B MONOAMINE-OXIDASE INHIBITOR IN 200 PATIENTS [J].

ELIZAN, TS ;

YAHR, MD ;

MOROS, DA ;

MENDOZA, MR ;

PANG, S ;

BODIAN, CA .

ARCHIVES OF NEUROLOGY, 1989, 46 (12) :1280-1283

[8]

Fahn S, 2004, NEW ENGL J MED, V351, P2498

[9]

Han SK, 1996, J NEUROCHEM, V66, P501

[10] Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease [J].

Lees, AJ .

BRITISH MEDICAL JOURNAL, 1995, 311 (7020) :1602-1607

← 1 2 3 →